
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock… read more
Simplify
ETF
Equity
- years
23 holdings
$18.28
Price+0.18%
$0.03
$78.437m
Small
$4.260k
Avg Volume$114.241m
-
NAV2.79%
Expense Ratio14.88%
Yield$2.72
Dividend